课题基金 / 基金详情

EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer

EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer
EMPOWER 研究:促进儿童癌症幸存者的 BC 筛查
批准号:
8305953
负责人:
Kevin Charles Oeffinger
金额:
$62.28万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-23 至 2014-07-31

项目摘要

项目成果

Kevin Charles Oeffinger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Women who have been treated with chest radiation for a childhood cancer frequently have multiple health problems and have a significantly increased risk of developing breast cancer at a young age (prior to their forties). Although breast cancer surveillance with annual mammography and adjunct breast MRI is recommended starting at age 25, most young women are not obtaining screening. We have conducted preliminary studies to identify important predictors of screening and successfully piloted an intervention leading to increased rates of breast cancer screening among this high risk population. To reduce the breast cancer related morbidity and mortality faced by women who survived childhood cancer, it is imperative to formally test behaviorally-based intervention studies intended to promote breast cancer surveillance. In the proposed 12-month intervention trial, among 330 women who are 25 to 39 years of age and who have not had a mammogram (or similar screening imaging study) in the preceding two years, we will test the efficacy of an intervention aimed at increasing the likelihood of successfully completing the recommended surveillance. The intervention, theoretically founded upon the Transtheoretical Model and the Health Belief Model, consists of a mailed tailored education intervention followed by a stage-based brief motivational interview delivered by telephone. The primary outcome is obtaining a mammogram during the 12-month study period, confirmed by medical record. We hypothesize that women randomized to the intervention group will have a 20% higher rate of screening mammography than women randomized to the attention control group. Secondary aims will include exploring moderating and mediating factors that predict mammogram completion and timing of the obtained surveillance, determining the percent of women who obtain an adjunct breast MRI and explore barriers to completing this imaging test (e.g., insurance/cost, physician authorization), and estimating the intervention replication costs and costs resulting from the intervention. The proposed EMPOWER (Encouraging Mammography/MRI and Preventive Opportunities for Women Exposed to Radiation) study brings together a research team with the necessary expertise and experience in both survivorship research and telephone delivered motivational interviewing with the unique resource of the 26-institution Childhood Cancer Survivor Study (CCSS). Notably, the CCSS represents the single largest cohort of women in the target population and the infrastructure to conduct the proposed study. This study will represent the first randomized controlled trial aimed at promoting breast cancer surveillance among women who are treated with chest radiation for a childhood cancer and will advance our understanding of this vulnerable group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
  • 批准号:
    10524174
  • 项目类别:
  • 资助金额:
    $21.01万
  • 财政年份:
    2020
  • 负责人:
    Kevin Charles Oeffinger
  • 依托单位:
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
  • 批准号:
    10159878
  • 项目类别:
  • 资助金额:
    $73.45万
  • 财政年份:
    2020
  • 负责人:
    Kevin Charles Oeffinger
  • 依托单位:
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study Supplement
  • 批准号:
    10381219
  • 项目类别:
  • 资助金额:
    $16.48万
  • 财政年份:
    2020
  • 负责人:
    Kevin Charles Oeffinger
  • 依托单位:
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
  • 批准号:
    10676075
  • 项目类别:
  • 资助金额:
    $74.49万
  • 财政年份:
    2020
  • 负责人:
    Kevin Charles Oeffinger
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: